FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048576319> ?p ?o ?g. }

• W2048576319 abstract "Combination of platinum derivatives with paclitaxel is currently the standard front line regimen for patients with epithelial ovarian carcinoma, and represents also an active regimen in patients with metastatic breast or unknown primary carcinomas. Measurement of intestinal permeability represents one of the potential methods of noninvasive laboratory assessment of gastrointestinal mucositis induced by chemotherapy, but little is known about intestinal permeability in patients treated with paclitaxel or platinum.Intestinal permeability was assessed in 36 breast and ovarian cancer patients treated with paclitaxel/platinum combination by measuring, using capillary gas chromatography, urinary sucrose, lactulose, xylose and mannitol after oral challenge. The significance of differences during the therapy compared to pre-treatment values was studied by Wilcoxon paired test. The differences between groups of patient were studied by Mann-Whitney U test. Fisher exact test was used to compare the frequency in different subgroups.After administration of the first dose, a significant (p < 0.05) decrease in xylose absorption and increased lactulose/mannitol, sucrose/mannitol, lactulose/xylose and sucrose/xylose ratios were observed, but these parameters returned subsequently to pre-treatment levels. Patients who experienced serious (grade 3 or 4) toxicity had at baseline significantly lower percentages of xylose, mannitol and sucrose, and higher lactulose/mannitol ratio. Nine of 13 (69%) patients with baseline lactulose/mannitol ratio 0.070 or above experienced serious toxicity compared to 4 out of 23 patients (17%) with the ratio below 0.070 (p = 0.002). Post-treatment lactulose, lactulose/mannitol, sucrose/mannitol and lactulose/xylose ratios were significantly increased in patients with serious toxicity.A transient significant increase in lactulose/monosaccharide and sucrose/monosaccharide ratios was observed in ovarian and breast cancer patients treated with paclitaxel and platinum. Increased lactulose absorption, lactulose/mannitol, sucrose/mannitol and lactulose/xylose ratios were evident in patients with grade 3 or 4 toxicity, and increased baseline lactulose/mannitol ratio predicted serious toxicity." @default.
• W2048576319 created "2016-06-24" @default.
• W2048576319 creator A5009523282 @default.
• W2048576319 creator A5035376363 @default.
• W2048576319 creator A5038039431 @default.
• W2048576319 creator A5055122791 @default.
• W2048576319 creator A5060115847 @default.
• W2048576319 creator A5061548362 @default.
• W2048576319 date "2007-08-09" @default.
• W2048576319 modified "2023-10-05" @default.
• W2048576319 title "Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum" @default.
• W2048576319 cites W1483551496 @default.
• W2048576319 cites W1803204108 @default.
• W2048576319 cites W1818021918 @default.
• W2048576319 cites W1857706035 @default.
• W2048576319 cites W1974306462 @default.
• W2048576319 cites W1978454448 @default.
• W2048576319 cites W1995458661 @default.
• W2048576319 cites W2008974621 @default.
• W2048576319 cites W2015066983 @default.
• W2048576319 cites W2020258168 @default.
• W2048576319 cites W2022975557 @default.
• W2048576319 cites W2028067695 @default.
• W2048576319 cites W2078673484 @default.
• W2048576319 cites W2084414443 @default.
• W2048576319 cites W2097105130 @default.
• W2048576319 cites W2112644262 @default.
• W2048576319 cites W2115980875 @default.
• W2048576319 cites W2125775222 @default.
• W2048576319 cites W2129949847 @default.
• W2048576319 cites W2143354760 @default.
• W2048576319 cites W2151789462 @default.
• W2048576319 cites W2152485160 @default.
• W2048576319 cites W2318850958 @default.
• W2048576319 cites W2328023807 @default.
• W2048576319 cites W2328421677 @default.
• W2048576319 cites W2404782310 @default.
• W2048576319 cites W3191629071 @default.
• W2048576319 doi "https://doi.org/10.1186/1471-2407-7-155" @default.
• W2048576319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1973082" @default.
• W2048576319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17688683" @default.
• W2048576319 hasPublicationYear "2007" @default.
• W2048576319 type Work @default.
• W2048576319 sameAs 2048576319 @default.
• W2048576319 citedByCount "14" @default.
• W2048576319 countsByYear W20485763192012 @default.
• W2048576319 countsByYear W20485763192013 @default.
• W2048576319 countsByYear W20485763192016 @default.
• W2048576319 countsByYear W20485763192019 @default.
• W2048576319 countsByYear W20485763192020 @default.
• W2048576319 countsByYear W20485763192021 @default.
• W2048576319 countsByYear W20485763192023 @default.
• W2048576319 crossrefType "journal-article" @default.
• W2048576319 hasAuthorship W2048576319A5009523282 @default.
• W2048576319 hasAuthorship W2048576319A5035376363 @default.
• W2048576319 hasAuthorship W2048576319A5038039431 @default.
• W2048576319 hasAuthorship W2048576319A5055122791 @default.
• W2048576319 hasAuthorship W2048576319A5060115847 @default.
• W2048576319 hasAuthorship W2048576319A5061548362 @default.
• W2048576319 hasBestOaLocation W20485763191 @default.
• W2048576319 hasConcept C100544194 @default.
• W2048576319 hasConcept C126322002 @default.
• W2048576319 hasConcept C185592680 @default.
• W2048576319 hasConcept C2776694085 @default.
• W2048576319 hasConcept C2777448540 @default.
• W2048576319 hasConcept C2778445172 @default.
• W2048576319 hasConcept C2780294150 @default.
• W2048576319 hasConcept C2781071285 @default.
• W2048576319 hasConcept C55493867 @default.
• W2048576319 hasConcept C71924100 @default.
• W2048576319 hasConcept C90924648 @default.
• W2048576319 hasConceptScore W2048576319C100544194 @default.
• W2048576319 hasConceptScore W2048576319C126322002 @default.
• W2048576319 hasConceptScore W2048576319C185592680 @default.
• W2048576319 hasConceptScore W2048576319C2776694085 @default.
• W2048576319 hasConceptScore W2048576319C2777448540 @default.
• W2048576319 hasConceptScore W2048576319C2778445172 @default.
• W2048576319 hasConceptScore W2048576319C2780294150 @default.
• W2048576319 hasConceptScore W2048576319C2781071285 @default.
• W2048576319 hasConceptScore W2048576319C55493867 @default.
• W2048576319 hasConceptScore W2048576319C71924100 @default.
• W2048576319 hasConceptScore W2048576319C90924648 @default.
• W2048576319 hasIssue "1" @default.
• W2048576319 hasLocation W20485763191 @default.
• W2048576319 hasLocation W20485763192 @default.
• W2048576319 hasLocation W20485763193 @default.
• W2048576319 hasLocation W20485763194 @default.
• W2048576319 hasOpenAccess W2048576319 @default.
• W2048576319 hasPrimaryLocation W20485763191 @default.
• W2048576319 hasRelatedWork W1525871018 @default.
• W2048576319 hasRelatedWork W1992851871 @default.
• W2048576319 hasRelatedWork W2060077640 @default.
• W2048576319 hasRelatedWork W2061679773 @default.
• W2048576319 hasRelatedWork W2078579326 @default.
• W2048576319 hasRelatedWork W2085174271 @default.
• W2048576319 hasRelatedWork W2128113547 @default.
• W2048576319 hasRelatedWork W2367846303 @default.
• W2048576319 hasRelatedWork W2396771173 @default.
• W2048576319 hasRelatedWork W4210259334 @default.
• W2048576319 hasVolume "7" @default.

• next